FARMACEUTISK NANOPARTIKELFORMIG SAMMENSÆTNING AF EN TACHYKININ- RECEPTOR-ANTAGONIST

FARMACEUTISK NANOPARTIKELFORMIG SAMMENSÆTNING AF EN TACHYKININ- RECEPTOR-ANTAGONIST

The present invention is directed to novel pharmaceutical compositions of the compound 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo)methylmorpholine. The pharmaceutical compositions of this invention useful in the treatment or preventio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LIVERSIDGE, ELAINE, SHELUKAR, SUHAS, D, BOSCH, WILLIAM, H, THOMPSON, KAREN, C
Format: Patent
Sprache:dan
Schlagworte:
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LIVERSIDGE, ELAINE
SHELUKAR, SUHAS, D
BOSCH, WILLIAM, H
THOMPSON, KAREN, C
description The present invention is directed to novel pharmaceutical compositions of the compound 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo)methylmorpholine. The pharmaceutical compositions of this invention useful in the treatment or prevention of disorders such as psychiatric disorders including depression and anxiety, inflammatory diseases and emesis.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_DK1455756TT4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>DK1455756TT4</sourcerecordid><originalsourceid>FETCH-epo_espacenet_DK1455756TT43</originalsourceid><addsrcrecordid>eNqNyjEOAiEQQFEaC6PeAQ9AYVy0nuDAEmTYwFhYbTYGK6ObrGfwYl5MCw9g9ZOXPxdsIUcweGJfgiSg1EFmH_BoU47eyQIxIpX3i8mTk2AlkmQw7Tn4ryiZ0WDHKSsgBpfIF16K2XW4TXX160KsLbJpVR0ffZ3G4VLv9dkfwqbReq93zM32n-cD46Qx2Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FARMACEUTISK NANOPARTIKELFORMIG SAMMENSÆTNING AF EN TACHYKININ- RECEPTOR-ANTAGONIST</title><source>esp@cenet</source><creator>LIVERSIDGE, ELAINE ; SHELUKAR, SUHAS, D ; BOSCH, WILLIAM, H ; THOMPSON, KAREN, C</creator><creatorcontrib>LIVERSIDGE, ELAINE ; SHELUKAR, SUHAS, D ; BOSCH, WILLIAM, H ; THOMPSON, KAREN, C</creatorcontrib><description>The present invention is directed to novel pharmaceutical compositions of the compound 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo)methylmorpholine. The pharmaceutical compositions of this invention useful in the treatment or prevention of disorders such as psychiatric disorders including depression and anxiety, inflammatory diseases and emesis.</description><language>dan</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160104&amp;DB=EPODOC&amp;CC=DK&amp;NR=1455756T4$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20160104&amp;DB=EPODOC&amp;CC=DK&amp;NR=1455756T4$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LIVERSIDGE, ELAINE</creatorcontrib><creatorcontrib>SHELUKAR, SUHAS, D</creatorcontrib><creatorcontrib>BOSCH, WILLIAM, H</creatorcontrib><creatorcontrib>THOMPSON, KAREN, C</creatorcontrib><title>FARMACEUTISK NANOPARTIKELFORMIG SAMMENSÆTNING AF EN TACHYKININ- RECEPTOR-ANTAGONIST</title><description>The present invention is directed to novel pharmaceutical compositions of the compound 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo)methylmorpholine. The pharmaceutical compositions of this invention useful in the treatment or prevention of disorders such as psychiatric disorders including depression and anxiety, inflammatory diseases and emesis.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyjEOAiEQQFEaC6PeAQ9AYVy0nuDAEmTYwFhYbTYGK6ObrGfwYl5MCw9g9ZOXPxdsIUcweGJfgiSg1EFmH_BoU47eyQIxIpX3i8mTk2AlkmQw7Tn4ryiZ0WDHKSsgBpfIF16K2XW4TXX160KsLbJpVR0ffZ3G4VLv9dkfwqbReq93zM32n-cD46Qx2Q</recordid><startdate>20160104</startdate><enddate>20160104</enddate><creator>LIVERSIDGE, ELAINE</creator><creator>SHELUKAR, SUHAS, D</creator><creator>BOSCH, WILLIAM, H</creator><creator>THOMPSON, KAREN, C</creator><scope>EVB</scope></search><sort><creationdate>20160104</creationdate><title>FARMACEUTISK NANOPARTIKELFORMIG SAMMENSÆTNING AF EN TACHYKININ- RECEPTOR-ANTAGONIST</title><author>LIVERSIDGE, ELAINE ; SHELUKAR, SUHAS, D ; BOSCH, WILLIAM, H ; THOMPSON, KAREN, C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_DK1455756TT43</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>dan</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LIVERSIDGE, ELAINE</creatorcontrib><creatorcontrib>SHELUKAR, SUHAS, D</creatorcontrib><creatorcontrib>BOSCH, WILLIAM, H</creatorcontrib><creatorcontrib>THOMPSON, KAREN, C</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LIVERSIDGE, ELAINE</au><au>SHELUKAR, SUHAS, D</au><au>BOSCH, WILLIAM, H</au><au>THOMPSON, KAREN, C</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FARMACEUTISK NANOPARTIKELFORMIG SAMMENSÆTNING AF EN TACHYKININ- RECEPTOR-ANTAGONIST</title><date>2016-01-04</date><risdate>2016</risdate><abstract>The present invention is directed to novel pharmaceutical compositions of the compound 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,2,4-triazolo)methylmorpholine. The pharmaceutical compositions of this invention useful in the treatment or prevention of disorders such as psychiatric disorders including depression and anxiety, inflammatory diseases and emesis.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language dan
recordid cdi_epo_espacenet_DK1455756TT4
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title FARMACEUTISK NANOPARTIKELFORMIG SAMMENSÆTNING AF EN TACHYKININ- RECEPTOR-ANTAGONIST
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T21%3A22%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LIVERSIDGE,%20ELAINE&rft.date=2016-01-04&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EDK1455756TT4%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true